Douglas E Onsi - Net Worth and Insider Trading
Douglas E Onsi Net Worth
The estimated net worth of Douglas E Onsi is at least $1 Million dollars as of 2024-11-13. Douglas E Onsi is the CFO, GC, Treasurer & Secretary, 10% Owner of Leap Therapeutics Inc and owns about 445,869 shares of Leap Therapeutics Inc (LPTX) stock worth over $1 Million. Details can be seen in Douglas E Onsi's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Douglas E Onsi has not made any transactions after 2019-02-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Douglas E Onsi
Douglas E Onsi Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Douglas E Onsi owns 2 companies in total, including Leap Therapeutics Inc (LPTX) , and TetraLogic Pharmaceuticals Corp (TLOG) .
Click here to see the complete history of Douglas E Onsi’s form 4 insider trades.
Insider Ownership Summary of Douglas E Onsi
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LPTX | Leap Therapeutics Inc | 2019-02-05 | 10 percent owner & CFO,Gen Counsel,Treas & Sec. |
| TLOG | TetraLogic Pharmaceuticals Corp | 2015-01-28 | director |
Douglas E Onsi Latest Holdings Summary
Douglas E Onsi currently owns a total of 1 stock. Douglas E Onsi owns 445,869 shares of Leap Therapeutics Inc (LPTX) as of February 5, 2019, with a value of $1 Million.
Latest Holdings of Douglas E Onsi
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LPTX | Leap Therapeutics Inc | 2019-02-05 | 445,869 | 3.25 | 1,449,074 |
Holding Weightings of Douglas E Onsi
Douglas E Onsi Form 4 Trading Tracker
According to the SEC Form 4 filings, Douglas E Onsi has made a total of 0 transactions in Leap Therapeutics Inc (LPTX) over the past 5 years. The most-recent trade in Leap Therapeutics Inc is the acquisition of 57,143 shares on February 5, 2019, which cost Douglas E Onsi around $999,999.
Insider Trading History of Douglas E Onsi
- 1
Douglas E Onsi Trading Performance
GuruFocus tracks the stock performance after each of Douglas E Onsi's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Douglas E Onsi is 13.8%. GuruFocus also compares Douglas E Onsi's trading performance to market benchmark return within the same time period. The performance of stocks bought by Douglas E Onsi within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Douglas E Onsi's insider trading performs compared to the benchmark.
Performance of Douglas E Onsi
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 7.14 | | | | | |
| Relative Return to S&P 500(%) | 4.77 | | | | | |
Douglas E Onsi Ownership Network
Ownership Network List of Douglas E Onsi
Ownership Network Relation of Douglas E Onsi
Douglas E Onsi Owned Company Details
What does Leap Therapeutics Inc do?
Who are the key executives at Leap Therapeutics Inc?
Douglas E Onsi is the 10 percent owner & CFO,Gen Counsel,Treas & Sec. of Leap Therapeutics Inc. Other key executives at Leap Therapeutics Inc include Chief Scientific Officer Jason Baum , 10 percent owner Beigene, Ltd. , and VP & Head of Reg Affairs/Qual Christine Granfield .
Leap Therapeutics Inc (LPTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Leap Therapeutics Inc (LPTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Leap Therapeutics Inc (LPTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Leap Therapeutics Inc (LPTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Leap Therapeutics Inc Insider Transactions
Douglas E Onsi Mailing Address
Above is the net worth, insider trading, and ownership report for Douglas E Onsi. You might contact Douglas E Onsi via mailing address: C/o Tolerrx Inc, 300 Technology Square, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
